MedTrace Logo

Intraperitoneal Ropivacaine Nebulization for Pain Control After Gynecologic Laparoscopic Surgery

NCT01142622 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2013-02-25

No results posted yet for this study

Summary

The purpose of this study is to assess if intraperitoneal nebulization of Ropivacaine 150 mg may prevent the use of morphine during the first day after laparoscopic ovarian cyst surgery.

Conditions

  • Ovarian Cysts

Interventions

DRUG

Ropivacaine nebulization

Preoperative nebulization of 150 mg of Ropivacaine in the peritoneal cavity.

DRUG

Ropivacaine instillation

Preoperative instillation of 150 mg of Ropivacaine in the peritoneal cavity.

Sponsors & Collaborators

  • A.O. Ospedale Papa Giovanni XXIII

    collaborator OTHER

  • San Gerardo Hospital

    lead OTHER

Principal Investigators

  • Pablo M Ingelmo, MD · San Gerardo Hospital, Monza. Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01142622 on ClinicalTrials.gov